This project has a Band 2 fee. Details of our different fee bands can be found on our website. For information on how to apply for this project, please visit the Faculty of Biology, Medicine and Health Doctoral Academy website. Informal enquiries may be made directly to the primary supervisor.
1.Gray-Schopfer V, Wellbrock C, Marais R (2007). Melanoma biology and new targeted therapy. Nature.;445(7130):851-7
2. Wellbrock C, Hurlstone A. (2010) BRAF as therapeutic target in melanoma. Biochem Pharmacol.;80(5):561-7
3. Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C. (2011) In
melanoma, beta-catenin is a suppressor of invasion. Oncogene;30(45):4531-43
4. Ferguson J, Arozarena I, Ehrhardt M, Wellbrock C. (2012) Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene, Feb 6. [Epub ahead of print] PubMed PMID: 22310287